Skip to main content
. 2001 Nov;104(3):349–354. doi: 10.1046/j.1365-2567.2001.01311.x

Figure 5.

Figure 5

Effect of treatment with anti-interleukin-2 (IL-2) monoclonal antibody (mAb) S4B6.31 on concanavalin A (Con A)-stimulated spleen cell proliferation from normal mice in cultures treated with interleukin-12 (IL-12) (a), and the effect of the same treatments on parasite antigen (T-Ag)-stimulated proliferation in NG-monomethyl-l-arginine (NMMA)-treated cultures of spleen cells obtained from day-12 Trypanosoma cruzi-infected mice (b). Values are expressed as arithmetic means of triplicate cultures ±standard deviation. The results are representative of three experiments.